← back to search

Kosta Steliou

Boston University · US
Area of research
Organic Chemistry · Molecular Biology
Research interest
Research interests include Chemical Synthesis and Reactions, Sulfur-Based Synthesis Techniques, Organic Chemistry Cycloaddition Reactions, and Mitochondrial Function and Pathology.
h-index
28
citations
2,304
works
88
NIH funding
primary concept
email

Recent publications

Epilepsy: Mitochondrial connections to the ‘Sacred’ disease
Mitochondrion 2023cited by 31position: middledoi
Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Biochemical Pharmacology 2022cited by 28position: middledoi
Pathogenic mitochondrial dysfunction and metabolic abnormalities
Biochemical Pharmacology 2021cited by 47position: middledoi
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs
BioResearch open access 2020cited by 34position: middledoi
Epigenetic treatment of dermatologic disorders
Drug Development Research 2019cited by 2position: middledoi
A New Approach to Treating Neurodegenerative Otologic Disorders
BioResearch open access 2018cited by 14position: middledoi
Toward Mitochondrial Medicine
2018cited by 0position: middledoi
Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something
BioResearch open access 2017cited by 77position: middledoi
Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future
BioResearch open access 2017cited by 16position: middledoi
Microbiota and Neurological Disorders: A Gut Feeling
BioResearch open access 2016cited by 148position: lastdoi
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases
Drug Development Research 2016cited by 56position: middledoi
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
Drug Development Research 2016cited by 39position: lastdoi
Epigenetic Treatment of Persistent Viral Infections
Drug Development Research 2016cited by 24position: lastdoi
Bioprotective Carnitinoids: Lipoic Acid, Butyrate, and Mitochondria‐Targeting to Treat Radiation Injury: Mitochondrial Drugs Come of Age
Drug Development Research 2015cited by 16position: firstdoi
Antioxidant‐Mediated Reversal of Oxidative Damage in Mouse Modeling of Complex I Inhibition
Drug Development Research 2015cited by 11position: middledoi
Butyrate Histone Deacetylase Inhibitors
BioResearch open access 2012cited by 197position: firstdoi
Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brain
Pharmacology Biochemistry and Behavior 2012cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Walter H. Moos · University of California, San Francisco14 papers (2015–2023)Carl A. Pinkert · Auburn University14 papers (2012–2023)Douglas V. Faller · Boston University14 papers (2012–2023) · 9 papers (2016–2023)Whitney R. Powers · Boston University9 papers (2016–2023) · 9 papers (2016–2023)Michael H. Irwin · Auburn University9 papers (2012–2018)David N. Harpp · McGill University8 papers (2016–2022)Ioannis P. Glavas · New York University8 papers (2016–2023)Demetrios G. Vavvas · University of Alabama at Birmingham7 papers (2017–2023) · 6 papers (2016–2023) · 5 papers (2017–2023) · 5 papers (2019–2023)Robert Zamboni · McGill University4 papers (2019–2022)Anastasios Mavrakis · Tufts University3 papers (2020–2022)Constantin Tamvakopoulos · National and Kapodistrian University of Athens2 papers (2021–2022) · 2 papers (2021–2022)Kodeeswaran Parameshwaran · California State University, Chico2 papers (2012–2015)Xiaohong Chen · Soochow University1 papers (2020–2020)Nikolaos S. Soukos · Northeastern University1 papers (2017–2017)